IsoPlexis to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
February 16 2022 - 7:00AM
IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company,
today announced it will report financial results for the fourth
quarter and full year 2021 before market open on Wednesday, March
2, 2022. Company management will be webcasting a corresponding
conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m.
Eastern Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.isoplexis.com. The webcast
will be archived and available for replay after the event.
About IsoPlexisIsoPlexis is the Superhuman Cell
company.
IsoPlexis’ systems uniquely identify a comprehensive range of
multifunctional single cells, i.e. the superhero cells in the human
body. These cells enable researchers to understand and predict
disease progression, treatment resistance and therapeutic efficacy
to advance all of human health.
IsoPlexis has been named Top Innovation or Design by The
Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple
others. The IsoPlexis platform is used globally by researchers,
including those at the top 15 global pharmaceutical companies and
at two-thirds of leading U.S. comprehensive cancer centers.
Investor
Contactinvestors@isoplexis.com
Press Contactpress@isoplexis.com
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Jun 2024 to Jul 2024
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Jul 2023 to Jul 2024